Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

1.

The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic.

Montaner JS, Hogg R, Wood E, Kerr T, Tyndall M, Levy AR, Harrigan PR.

Lancet. 2006 Aug 5;368(9534):531-6. Review. No abstract available.

PMID:
16890841
[PubMed - indexed for MEDLINE]
2.

HIV prevention and treatment in Africa.

Laurence J.

AIDS Patient Care STDS. 2000 Aug;14(8):399-400. No abstract available.

PMID:
10977967
[PubMed - indexed for MEDLINE]
3.

Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic.

Lima VD, Johnston K, Hogg RS, Levy AR, Harrigan PR, Anema A, Montaner JS.

J Infect Dis. 2008 Jul 1;198(1):59-67. doi: 10.1086/588673.

PMID:
18498241
[PubMed - indexed for MEDLINE]
Free Article
4.

Balancing effectiveness and access to HIV treatment in the developing world.

Hill A, Wood E.

AIDS. 2007 Jan 30;21(3):361-3. No abstract available.

PMID:
17255743
[PubMed - indexed for MEDLINE]
5.

Global situation of the HIV/AIDS pandemic, end 2003. Part II: Estimating ARV global treatment needs (2003-2005).

[No authors listed]

Wkly Epidemiol Rec. 2003 Dec 12;78(50):426-30. English, French. No abstract available.

PMID:
14702672
[PubMed - indexed for MEDLINE]
6.

Does antiretroviral therapy prevent HIV transmission to sexual partners?

Lalani T, Hicks C.

Curr HIV/AIDS Rep. 2007 May;4(2):80-5. Review.

PMID:
17547829
[PubMed - indexed for MEDLINE]
7.

A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy.

Bezemer D, de Wolf F, Boerlijst MC, van Sighem A, Hollingsworth TD, Prins M, Geskus RB, Gras L, Coutinho RA, Fraser C.

AIDS. 2008 May 31;22(9):1071-7. doi: 10.1097/QAD.0b013e3282fd167c.

PMID:
18520351
[PubMed - indexed for MEDLINE]
8.

HIV update 2005: origins, issues, prospects, and complications.

Armstrong W, Calabrese L, Taege AJ.

Cleve Clin J Med. 2005 Jan;72(1):73-8. Review.

PMID:
15691060
[PubMed - indexed for MEDLINE]
Free Article
9.

Is antiretroviral therapy cost-effective in South Africa?

Braithwaite RS, Tsevat J.

PLoS Med. 2006 Jan;3(1):e60. Epub 2006 Jan 31. No abstract available.

PMID:
16435892
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

[5th French-speaking conference on HIV/AIDS (Casablanca, 28-31 March 2010)].

Milleliri JM, Goudjo A.

Med Trop (Mars). 2010 Jun;70(3):226-8. French. No abstract available.

PMID:
20734588
[PubMed - indexed for MEDLINE]
11.

The economic viability of antiretroviral adherence interventions.

Bozzette SA, Gifford AL.

Am J Med. 2003 Dec 1;115(8):672-3. No abstract available.

PMID:
14656623
[PubMed - indexed for MEDLINE]
12.

Losing sight of HIV prevention.

Voelker R.

IAPAC Mon. 2000 Nov;6(11):312-5. No abstract available.

PMID:
11299993
[PubMed - indexed for MEDLINE]
13.

New trends in HIV disease worldwide.

Laurence J.

AIDS Read. 2003 Dec;13(12):569-70. Review. No abstract available.

PMID:
14959689
[PubMed - indexed for MEDLINE]
14.

AIDS prevention more cost-effective than HAART treatment.

[No authors listed]

AIDS Policy Law. 2002 Jun 7;17(11):2. No abstract available.

PMID:
12083037
[PubMed - indexed for MEDLINE]
15.

Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia.

Long EF, Brandeau ML, Galvin CM, Vinichenko T, Tole SP, Schwartz A, Sanders GD, Owens DK.

AIDS. 2006 Nov 14;20(17):2207-15.

PMID:
17086061
[PubMed - indexed for MEDLINE]
16.

Inequalities in health: access to treatment for HIV/AIDS.

Giuliano M, Vella S.

Ann Ist Super Sanita. 2007;43(4):313-6. Review.

PMID:
18209264
[PubMed - indexed for MEDLINE]
Free Article
17.

The human right to health, national courts, and access to HIV/AIDS treatment: a case study from Venezuela.

Torres MA.

Chic J Int Law. 2002 Spring;3(1):105-14. No abstract available.

PMID:
15709302
[PubMed - indexed for MEDLINE]
18.

Cost-effectiveness of alternative strategies for initiating and monitoring highly active antiretroviral therapy in the developing world.

Vijayaraghavan A, Efrusy MB, Mazonson PD, Ebrahim O, Sanne IM, Santas CC.

J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):91-100.

PMID:
17621241
[PubMed - indexed for MEDLINE]
19.

The costs of HIV antiretroviral therapy adherence programs and impact on health care utilization.

Sansom SL, Anthony MN, Garland WH, Squires KE, Witt MD, Kovacs Andrea A, Larsen RA, Valencia R, Pals SL, Hader S, Weidle PJ, Wohl AR.

AIDS Patient Care STDS. 2008 Feb;22(2):131-8. doi: 10.1089/apc.2006.0216.

PMID:
18260804
[PubMed - indexed for MEDLINE]
20.

HIV/AIDS, utilities, and cost-effectiveness analysis: stepping toward the future.

Holmes WC.

Med Decis Making. 2002 Nov-Dec;22(6):522-5. No abstract available.

PMID:
12458983
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk